← Browse by Condition
Medical Condition

cardiotoxicity

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3
NCT04822077
Recruiting

Study on Proton Radiotherapy of Thymic Malignancies

Enrollment
40 pts
Location
Sweden
Sponsor
Ass. Prof. Jan Nyman
View Trial →
NCT05732051 Phase 2
Recruiting

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Enrollment
60 pts
Location
Norway
Sponsor
University Hospital, Akershus
View Trial →
NCT05921279
Recruiting

Understanding CARdiac Events in Breast Cancer

Enrollment
100 pts
Location
Ireland
Sponsor
National University of Ireland...
View Trial →
NCT05851053
Recruiting

Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study

Enrollment
455 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT05271162 Phase 3
Recruiting

Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines

Enrollment
220 pts
Location
Poland
Sponsor
Maria Sklodowska-Curie Nationa...
View Trial →